Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 16Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 14Neoplasm Metastasis 7Brain Neoplasms 7Sarcoma 2Melanoma 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Carcinoma, Small Cell 2Breast Neoplasms 2Adenocarcinoma of Lung 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Cancer Recurrent 1SCLC, Extensive Stage 1Recurrent Extensive Stage Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Non Small Cell Lung Cancer Metastatic 1Neuroendocrine Tumors 1Neoplasms, Second Primary 1Mesothelioma 1Extensive Stage Small Cell Lung Cancer 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Neuroendocrine 1Carcinoma, Large Cell 1Carcinoma 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

lorlatinib 3pembrolizumab 2osimertinib 2Radiotherapy 2atezolizumab 1Temozolomide 1Radiosurgery 1Paclitaxel 1Nivolumab 1Ipilimumab 1Fecal Microbiota Transplantation 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non Small Cell Lung Cancer Metastatic × Temozolomide × Thoracic × Clear all
NCT03732482 2019-01-29

Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases

Taizhou Hospital

Phase 2/3 Unknown
400 enrolled
Thoracic

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡